PubMed Health⌕ Search

PubMed · 7885673

Low vision magnifiers--their optical parameters and methods for prescribing.

Abstract

Information provided by manufacturers of low vision magnifiers is usually insufficient to allow the clinician to predict accurately the resolution improvement that patients may be expected to achieve. We have measured and tabulated the key optical parameters of 92 stand magnifiers and 53 hand-held magnifiers. For the fixed focus stand magnifiers, the image location and the equivalent power of the lens system have been determined and the enlargement ratio has been derived. For each magnifier, 3 different eye-to-lens distances (2.5, 10, and 25 cm) have been considered and, for each of these, the Equivalent Viewing Distance (EVD), the eye-to-image distance, and the theoretically predicted field width have been computed. The EVD is useful in predicting resolution performance because, for a given patient, the visual resolution limit will be directly proportional to the EVD. The eye-to-image distances allow the clinician to consider whether the patient will be in satisfactory focus or whether adjustments need to be made to the power of any reading addition. The stand magnifiers are listed in order of the EVD they give when the eye is a moderate (10 cm) distance from the magnifier. For the hand-held magnifiers, the equivalent powers have been measured. The EVD for a hand-held magnifier will be the same as the equivalent focal length of the magnifier if the lens is used so that the image is at or close to infinity. The tables include supplementary information on the size of the magnifier lenses and whether the magnifiers incorporate battery, electric, incandescent, or halogen lighting systems. Examples are presented to illustrate how the tables might be used in the selection of magnifiers to meet the resolution and other needs of individual patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

I L Bailey, M A Bullimore, R B Greer, W B Mattingly. 1994. Low vision magnifiers--their optical parameters and methods for prescribing.. https://doi.org/10.1097/00006324-199411000-00004

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗